Ossiam Edwards Lifesciences Corp Transaction History

Ossiam

$5.65 Billion
Q1 2024

A detailed history of Ossiam transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ossiam holds 33,088 shares of EW stock, worth $3.02 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

33,088

Previous 29,055 13.88%

Holding current value

$3.02 Million

Previous $2.22 Million 42.71%

% of portfolio

0.06%

Previous 0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$72.54 - $95.56 $292,553 - $385,393	4,033 Added 13.88%	33,088 $3.16 Million
Q4 2023 Feb 13, 2024	BUY	$61.71 - $77.76 $120,643 - $152,020	1,955 Added 7.21%	29,055 $2.22 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $6.34 Million - $8.55 Million	-91,539 Reduced 77.16%	27,100 $1.88 Million
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $7.02 Million - $8.13 Million	86,214 Added 265.89%	118,639 $11.2 Million
Q1 2023 May 12, 2023	BUY	$74.26 - $84.51 $516,107 - $587,344	6,950 Added 27.28%	32,425 $2.68 Million

Q4 2022 Feb 13, 2023	SELL	$68.3 - $87.44 $93,844 - $120,142	-1,374 Reduced 5.12%	25,475 $1.9 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $790,504 - $1.03 Million	9,597 Added 55.63%	26,849 $2.22 Million
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $11.1 Million - $16.5 Million	-128,505 Reduced 88.16%	17,252 $1.64 Million
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $1.23 Million - $1.55 Million	-12,060 Reduced 7.64%	145,757 $17.2 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $867,553 - $1.07 Million	-8,156 Reduced 4.91%	157,817 $20.4 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $607,374 - $724,470	5,902 Added 3.69%	165,973 $18.8 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $1.51 Million - $1.88 Million	-17,978 Reduced 10.1%	160,071 $18 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $2.55 Million - $2.93 Million	32,365 Added 22.22%	178,049 $14.9 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $5.41 Million - $6.89 Million	75,532 Added 107.67%	145,684 $13.3 Million
Q3 2020 Nov 12, 2020	SELL	$67.19 - $87.44 $111,132 - $144,625	-1,654 Reduced 2.3%	70,152 $5.6 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $1.88 Million - $2.52 Million	32,686 Added 83.55%	71,806 $4.96 Million
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $2.03 Million - $3.14 Million	38,716 Added 9583.17%	39,120 $7.38 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $54,707 - $62,634	-763 Reduced 65.38%	404 $94,000
Q3 2019 Nov 13, 2019	BUY	$61.55 - $75.43 $55,456 - $67,962	901 Added 338.72%	1,167 $257,000
Q2 2019 Aug 13, 2019	SELL	$55.74 - $64.41 $131,211 - $151,621	-2,354 Reduced 89.85%	266 $49,000
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $74,995 - $100,302	1,566 Added 148.58%	2,620 $501,000
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $48,916 - $60,014	1,054 New	1,054 $161,000

Others Institutions Holding EW

# of Institutions

1,376

Shares Held

454M

Call Options Held

3.86M

Put Options Held

3.32M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $56.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.

Account